APA (7th ed.) Citation

Higuchi, K., Komori, S., Tanabe, S., Katada, C., Azuma, M., Ishiyama, H., . . . Koizumi, W. (2014). Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2). International journal of radiation oncology, biology, physics, 89(4), 872-879. https://doi.org/10.1016/j.ijrobp.2014.03.030

Chicago Style (17th ed.) Citation

Higuchi, Katsuhiko, et al. "Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)." International Journal of Radiation Oncology, Biology, Physics 89, no. 4 (2014): 872-879. https://doi.org/10.1016/j.ijrobp.2014.03.030.

MLA (9th ed.) Citation

Higuchi, Katsuhiko, et al. "Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)." International Journal of Radiation Oncology, Biology, Physics, vol. 89, no. 4, 2014, pp. 872-879, https://doi.org/10.1016/j.ijrobp.2014.03.030.